CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction
about
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardiumVascular Ageing and Exercise: Focus on Cellular Reparative ProcessesChemokine Regulation of Angiogenesis During Wound HealingMIF and CXCL12 in Cardiovascular Diseases: Functional Differences and SimilaritiesLoss of the cytoskeletal protein Pdlim7 predisposes mice to heart defects and hemostatic dysfunctionAngiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart DiseaseEffect of chemokine receptor CXCR4 on hypoxia-induced pulmonary hypertension and vascular remodeling in ratsStromal cell-derived factor-1α and transforming growth factor-β1 synergistically facilitate migration and chondrogenesis of synovium-derived stem cells through MAPK pathways.Period 2 is essential to maintain early endothelial progenitor cell function in vitro and angiogenesis after myocardial infarction in mice.Prostaglandin E2 promotes endothelial differentiation from bone marrow-derived cells through AMPK activationCombinatorial G-CSF/AMD3100 treatment in cardiac repair after myocardial infarction.Modulation of stromal cell-derived factor-1/CXC chemokine receptor 4 axis enhances rhBMP-2-induced ectopic bone formation.Specific inhibition of HDAC4 in cardiac progenitor cells enhances myocardial repairs.Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus.Human endothelial stem/progenitor cells, angiogenic factors and vascular repair.Harnessing developmental processes for vascular engineering and regeneration.Targeting stem cell niches and trafficking for cardiovascular therapyStem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challengesEndogenous endothelial progenitor cells participate in neovascularization via CXCR4/SDF-1 axis and improve outcome after stroke.Inhibition of the CXCL12/CXCR4 chemokine axis with AMD3100, a CXCR4 small molecule inhibitor, worsens murine hepatic injury.Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction.Endothelial progenitor cells in cardiovascular diseases: from biomarker to therapeutic agentRecent concepts for the roles of progenitor/stem cell niche in heart repair.CXCR4 blockade attenuates hyperoxia-induced lung injury in neonatal ratsCXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice.Cloning, expression and identification of an isoform of human stromal cell derived factor-1αEndothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent.Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9.Enhancing endothelial progenitor cell for clinical use.Continuous AMD3100 Treatment Worsens Renal Fibrosis through Regulation of Bone Marrow Derived Pro-Angiogenic Cells Homing and T-Cell-Related Inflammation.De-novo collateral formation following acute myocardial infarction: Dependence on CCR2⁺ bone marrow cells.Vein graft neointimal hyperplasia is exacerbated by CXCR4 signaling in vein graft-extrinsic cells.Inhibition of Oct 3/4 mitigates the cardiac progenitor-derived myocardial repair in infarcted myocardium.Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering.Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism.Wnt11 Gene Therapy with Adeno-associated Virus 9 Improves Recovery from Myocardial Infarction by Modulating the Inflammatory Response.
P2860
Q24306365-D4732BAF-867D-4729-93A0-4AA039910D94Q24629800-3A0A979C-EE62-4B18-9BC7-757F7D6387E3Q26772296-4DE998CF-5013-4FBE-BF2C-F05777DA141BQ26778691-507588C6-7704-4B74-92D8-89DE2852EB5DQ26800135-353FBDF2-6334-44B7-89D6-039A2DCEAADFQ27301488-DA45E450-6A93-45A9-B33C-7FAE0882D6A5Q27340828-4E21388E-2261-4941-9381-CF37C3157D00Q28569530-22ABD7A8-D700-4C9C-8D5D-C2E98A78E524Q33733311-738C7207-39BB-46B6-8A33-795DA62A6599Q33991672-40F39831-817F-4BD0-AA0A-4C92D2437D2EQ34005498-4A830421-16F1-4295-B30A-43B901E34C6AQ34046814-10D04207-D518-4017-9623-43FC69E7F7C2Q34060825-334E0B94-10A6-43D5-9757-342802ACC9A6Q34062891-D027AE41-DCE9-47DA-90A8-AAA64DD4ECFCQ34246928-8BA8DB3A-0698-4552-B965-883D3FEA6860Q34297873-5FE2C7D4-DB8F-4CA4-BABD-3C499469E08AQ34328240-7F621023-0D96-4501-9D0D-F533FE00371EQ34333348-20D6E079-B30D-4DB1-AB06-BDA521DA42AFQ34341522-67B5324C-A5CE-4134-A282-CDB7F8CFE176Q34475689-2775FD30-F5A0-44A4-841B-E8FE86490F5CQ34981433-B5999483-8376-4BDC-8574-F58026ED8C5BQ35104883-19C21803-FFAA-4914-8129-D92513DD24D6Q35132609-2E8B7A1C-A2B7-4C8F-91D6-473BFCED9863Q35386562-FB38322D-7F75-41FE-9848-AA90D81F3127Q35604291-0B91E433-B8A6-4B96-A240-D64A79CBA112Q35669620-E6AC75A7-B801-4499-B67A-E3920691B5EFQ35690521-41ADB2F5-D921-41B3-A0B7-DC735609D795Q35748620-C430589E-40B7-499B-9B7C-B464D2C2E9AAQ35753971-FB723BB1-279B-4450-90BD-7DCEBB59AE4DQ35774189-826E7CDD-A4DA-4F75-9A96-A4FD141D4D1CQ35809394-1321F32F-6421-4C57-AB43-1D246A1341AAQ35890200-B9C10652-E4BC-4D07-9FC7-3399FAE7FDF4Q35930523-75C685E7-A69B-4797-9CEF-EA62EDD1E87BQ36260190-009643DA-BAE8-4975-A459-57355C0FA888Q36339349-D33385AF-7B5E-431B-B9AD-ABFEC188C65BQ36401882-892CBD2B-B6FB-4204-AEAF-3AA81CEAB5A2Q36428933-0992D30F-FEB0-494B-876B-159FDCE033A1Q36445393-7E6786C4-9D2D-421B-9B3E-371485191F5FQ36576314-421754EA-CB67-4842-B0D8-E831A11BEFF0Q36587736-1333231C-4E0C-4AD0-9C71-5C91E63ACE6C
P2860
CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CXCR4 blockade augments bone m ...... ty after myocardial infarction
@ast
CXCR4 blockade augments bone m ...... ty after myocardial infarction
@en
type
label
CXCR4 blockade augments bone m ...... ty after myocardial infarction
@ast
CXCR4 blockade augments bone m ...... ty after myocardial infarction
@en
prefLabel
CXCR4 blockade augments bone m ...... ty after myocardial infarction
@ast
CXCR4 blockade augments bone m ...... ty after myocardial infarction
@en
P2093
P2860
P356
P1476
CXCR4 blockade augments bone m ...... ty after myocardial infarction
@en
P2093
Atsushi Iwakura
Douglas W Losordo
Ekaterina Klyachko
Haruki Sekiguchi
Hiromichi Hamada
Jérôme Roncalli
Jörn Tongers
Kentaro Jujo
Koichi Kobayashi
P2860
P304
11008-11013
P356
10.1073/PNAS.0914248107
P407
P577
2010-06-01T00:00:00Z